Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
AMERISAFE
AMSF
$504M
| $8.94M | 0.01% |
171,993
-17,000
| -9% | -$900K |
|
1152
Viking Therapeutics
VKTX
$3.84B
| $8.94M | 0.01% |
950,600
-95,800
| -9% | -$428K |
|
1153
Hancock Whitney
HWC
$6.37B
| $8.93M | 0.01% |
184,573
-15,100
| -8% | -$781K |
|
1154
Yeti Holdings
YETI
$3.44B
| $8.93M | 0.01% |
216,080
+128,280
| +146% | +$4.82M |
|
1155
iShares Core US Aggregate Bond ETF
AGG
$138B
| $8.91M | 0.01% |
+91,900
| New | +$8.89M |
|
1156
QuantumScape Corp
QS
$3.79B
| $8.91M | 0.01% |
1,571,400
-48,700
| -3% | -$361K |
|
1157
NVE Corp
NVEC
$563M
| $8.9M | 0.01% |
137,500
-5,800
| -4% | -$354K |
|
1158
J&J Snack Foods
JJSF
$1.7B
| $8.89M | 0.01% |
59,406
+3,350
| +6% | +$497K |
|
1159
GoodRx Holdings
GDRX
$1.27B
| $8.89M | 0.01% |
1,907,222
-314,400
| -14% | -$1.55M |
|
1160
Tronox
TROX
$958M
| $8.88M | 0.01% |
647,600
+306,700
| +90% | +$4.08M |
|
1161
Maximus
MMS
$2.94B
| $8.87M | 0.01% |
121,000
-79,700
| -40% | -$5.14M |
|
1162
First Busey Corp
BUSE
$2.58B
| $8.85M | 0.01% |
357,839
-30,092
| -8% | -$754K |
|
|
MRC
1163
DELISTED
MRC Global
MRC
| $8.81M | 0.01% |
760,900
-9,300
| -1% | -$98.1K |
|
|
DOOR
1164
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $8.81M | 0.01% |
109,300
+36,700
| +51% | +$2.71M |
|
1165
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$3.18B
| $8.81M | 0.01% |
+193,100
| New | +$8.67M |
|
1166
Ecopetrol
EC
$35.4B
| $8.8M | 0.01% |
840,330
-388,100
| -32% | -$3.78M |
|
1167
Idacorp
IDA
$8.16B
| $8.78M | 0.01% |
81,399
-13,000
| -14% | -$1.35M |
|
1168
Privia Health
PRVA
$2.78B
| $8.76M | 0.01% |
385,909
+238,709
| +162% | +$6.64M |
|
|
ICPT
1169
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $8.76M | 0.01% |
708,300
-30,900
| -4% | -$438K |
|
1170
DexCom
DXCM
$34.5B
| $8.75M | 0.01% |
77,300
+71,400
| +1,210% | +$7.84M |
|
|
MYOV
1171
DELISTED
Myovant Sciences Ltd.
MYOV
| $8.75M | 0.01% |
324,600
+36,100
| +13% | +$950K |
|
1172
Western Union
WU
$2.34B
| $8.75M | 0.01% |
635,300
+451,600
| +246% | +$6.24M |
|
1173
Fortive
FTV
$18.6B
| $8.71M | 0.01% |
+179,941
| New | +$8.72M |
|
1174
CNX Resources
CNX
$5.23B
| $8.71M | 0.01% |
516,900
-342,995
| -40% | -$5.92M |
|
|
MDC
1175
DELISTED
M.D.C. Holdings, Inc.
MDC
| $8.7M | 0.01% |
275,420
+239,700
| +671% | +$7.41M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.